Colorectal cancer is the third most commonly occurring cancer worldwide and gastrointestinal endoscopic mucosal resection (EMR) is a procedure to remove early-stage cancer and precancerous growths from the lining of the digestive tract. The use of submucosal injection is essential for the majority of EMR techniques while the injection provides a lifting up effect of the lesion separating it from the muscular layer, thereby reducing thermal injury and the risk of perforation and bleeding.
EsGel is the hydrogel for therapeutic endoscopy procedures and can be applied to submucosal dissections and polypectomies which improve the safety of therapeutic endoscopy by providing a submucosal cushion for the gastrointestinal tract.
【Highlight of EsGel】
EsGel can be used to lift this lesions from gastrointestinal mucosa and facilitate its endoscopic removal.
Welcome to S504 for the services and further collaborations with T-ACE Medical Co., Ltd.
》Cooperation projects and needs：1.Smart Wristband and cloud-based service: Promotion and application; 2.Looking for distribution channel-agents and International medicine